In this episode, we’re talking about biotech and health. If this past year and a half is any indication, investment in these sectors is critical. We’ve seen how we can confront a global pandemic with fast-tracked RNA-based vaccines. We’ve harnessed genomics to track and diagnose illness as it spreads. And the rise of telemedicine has made healthcare more accessible to all. 

Amy talked with Twist Bioscience CEO and Co-founder Emily LeProust about the MIC winner's cutting-edge technology that has pioneered what’s known as synthetic DNA. It’s used in therapeutics and precision medicine, but has applications across agriculture, biomaterials, and even data storage.